Choose a language and wait for the translated text.
China and India are home to some of the world's largest diabetes patient populations, accounting for more than 25% and 15% of global diagnosed cases, respectively, while about 12% of Brazilian adults have diabetes, according to J.P. Morgan.
GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says | PharmaVoice
